Irradiation in the prevention of transfusion associated graft-versus-host disease
- PMID: 8554351
- PMCID: PMC1511357
- DOI: 10.1136/adc.73.5.388
Irradiation in the prevention of transfusion associated graft-versus-host disease
Similar articles
-
Prevention of transfusion-associated graft-versus-host disease.Lancet. 1994 May 28;343(8909):1365-6. doi: 10.1016/s0140-6736(94)92503-8. Lancet. 1994. PMID: 7910356 No abstract available.
-
Amotosalen/UVA treatment inactivates T cells more effectively than the recommended gamma dose for prevention of transfusion-associated graft-versus-host disease.Transfusion. 2018 Jun;58(6):1506-1515. doi: 10.1111/trf.14589. Epub 2018 Apr 2. Transfusion. 2018. PMID: 29607502
-
Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.Transfus Med. 1996 Sep;6(3):261-71. Transfus Med. 1996. PMID: 8885157 No abstract available.
-
Prevention of transfusion-associated graft-versus-host disease by inactivation of T cells in platelet components.Semin Hematol. 2001 Oct;38(4 Suppl 11):34-45. doi: 10.1016/s0037-1963(01)90122-2. Semin Hematol. 2001. PMID: 11727284 Review.
-
Posttransfusion graft-versus-host disease in infancy.J Pediatr. 1990 Jul;117(1 Pt 1):159-63. doi: 10.1016/s0022-3476(05)82460-6. J Pediatr. 1990. PMID: 2196356 Review. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical